| New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. | |
| | |
MedLine Citation:
|
PMID: 23299917 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Cardiomyopathies are a heterogeneous group of diseases with various etiologies. We focused on three genetically determined cardiomyopathies: hypertrophic (HCM), dilated (DCM), and arrhythmogenic right ventricular cardiomyopathy (ARVC). Eighty-four genes have so far been associated with these cardiomyopathies, but the disease-causing effect of reported variants is often dubious. In order to identify possible false-positive variants, we investigated the prevalence of previously reported cardiomyopathy-associated variants in recently published exome data. We searched for reported missense and nonsense variants in the NHLBI-Go Exome Sequencing Project (ESP) containing exome data from 6500 individuals. In ESP, we identified 94 variants out of 687 (14%) variants previously associated with HCM, 58 out of 337 (17%) variants associated with DCM, and 38 variants out of 209 (18%) associated with ARVC. These findings correspond to a genotype prevalence of 1:4 for HCM, 1:6 for DCM, and 1:5 for ARVC. PolyPhen-2 predictions were conducted on all previously published cardiomyopathy-associated missense variants. We found significant overrepresentation of variants predicted as being benign among those present in ESP compared with the ones not present. In order to validate our findings, seven variants associated with cardiomyopathy were genotyped in a control population and this revealed frequencies comparable with the ones found in ESP. In conclusion, we identified genotype prevalences up to more than one thousand times higher than expected from the phenotype prevalences in the general population (HCM 1:500, DCM 1:2500, and ARVC 1:5000) and our data suggest that a high number of these variants are not monogenic causes of cardiomyopathy.European Journal of Human Genetics advance online publication, 9 January 2013; doi:10.1038/ejhg.2012.283. |
| | |
Authors:
|
Charlotte Andreasen; Jonas B Nielsen; Lena Refsgaard; Anders G Holst; Alex H Christensen; Laura Andreasen; Ahmad Sajadieh; Stig Haunsø; Jesper H Svendsen; Morten S Olesen |
Related Documents
:
|
23285067 - Genetic polymorphisms of the main transcription factors for adiponectin gene promoter i... 23495707 - Molecular diagnosis of celiac disease: are we there yet? 23566847 - Cc chemokine receptor-3 as new target for age related macular degeneration. 23537997 - Snv and haplotype analysis reveals new csrp1 variants associated with growth and carcas... 8023317 - Hla and disease associations: detecting the strongest association. 12634867 - Mapping of a new autosomal recessive nonsyndromic hearing loss locus (dfnb32) to chromo... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-1-09 |
Journal Detail:
|
Title: European journal of human genetics : EJHG Volume: - ISSN: 1476-5438 ISO Abbreviation: Eur. J. Hum. Genet. Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-1-9 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9302235 Medline TA: Eur J Hum Genet Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
1] The Danish National Research Foundation Centre for Cardiac Arrhythmia, Copenhagen, Denmark [2] Laboratory of Molecular Cardiology, The Heart Centre, University Hospital of Copenhagen, Rigshospitalet, Denmark. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A convenient chemical-microbial method for developing fluorinated pharmaceuticals.
Next Document: Broad consent versus dynamic consent in biobank research: Is passive participation an ethical proble...